Head To Head Should drug companies be allowed to talk directly to patients?: NO BMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7402.1302-a (Published 12 June 2003) Cite this as: BMJ 2003;326:1302 Article Related content Metrics Responses Peer review Related articles News Drug companies want to inform patients Published: 12 June 2003; BMJ 326 doi:10.1136/bmj.326.7402.1286-a Feature Industry funded patient information and the slippery slope to New Zealand Published: 04 October 2007; BMJ 335 doi:10.1136/bmj.39346.525764.AD See more Diabetes UK defends partnership with Slimming World in face of criticism BMJ April 26, 2024, 385 q962; DOI: https://doi.org/10.1136/bmj.q962 Type 1 diabetes: Randox removes adverts after claims that it was using fear to sell genetic test BMJ March 25, 2024, 384 q744; DOI: https://doi.org/10.1136/bmj.q744 FDA approves first over-the-counter blood glucose monitor for diabetes BMJ March 11, 2024, 384 q611; DOI: https://doi.org/10.1136/bmj.q611 US food manufacturer can say that eating yogurt reduces risk of type 2 diabetes, says FDA BMJ March 06, 2024, 384 q569; DOI: https://doi.org/10.1136/bmj.q569 Scarlett McNally: Preventing obesity is different from curing it—and even more urgent BMJ January 23, 2024, 384 q134; DOI: https://doi.org/10.1136/bmj.q134